eXoZymes (NASDAQ:EXOZ) Announces Quarterly Earnings Results

eXoZymes (NASDAQ:EXOZ) issued its quarterly earnings results on Thursday. The company reported ($0.28) earnings per share for the quarter, FiscalAI reports.

eXoZymes Stock Down 2.8%

NASDAQ EXOZ traded down $0.28 during trading hours on Thursday, hitting $9.61. 3,457 shares of the company were exchanged, compared to its average volume of 2,622. The company has a 50 day moving average of $9.06 and a two-hundred day moving average of $11.10. The company has a quick ratio of 2.51, a current ratio of 2.51 and a debt-to-equity ratio of 0.02. eXoZymes has a 52-week low of $7.08 and a 52-week high of $18.40. The firm has a market cap of $81.45 million, a price-to-earnings ratio of -8.89 and a beta of 2.85.

eXoZymes Company Profile

eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.

Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.

eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.